Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer's disease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33273062.
- Also identified by DOI 10.1126/science.aaw0843 and PMC identifier 8091809.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Here we describe mechanistically distinct enzymes (a kinase, a guanosine triphosphatase, and a ubiquitin protein hydrolase) that function in disparate biochemical pathways and can also act in concert to mediate a series of redox reactions. Each enzyme manifests a second, noncanonical function-transnitrosylation-that triggers a pathological biochemical cascade in mouse models and in humans with Alzheimer's disease (AD). The resulting series of transnitrosylation reactions contributes to synapse loss, the major pathological correlate to cognitive decline in AD. We conclude that enzymes with distinct primary reaction mechanisms can form a completely separate network for aberrant transnitrosylation. This network operates in the postreproductive period, so natural selection against such abnormal activity may be decreased.
Medical subject headings
- Alzheimer Disease
- Cyclin-Dependent Kinase 5
- Dynamins
- Nitric Oxide
- Nitric Oxide Synthase
- Synapses